Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
D000409:Alanine / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000032:analysis; D001424:Bacterial Infections / Q000188:drug therapy; D002473:Cell Wall / Q000032:analysis; D004926:Escherichia coli / Q000187:drug effects; D005461:Fluorine / Q000494:pharmacology / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy; D051379:Mice; D010777:Photochemistry; D011008:Pneumococcal Infections / Q000188:drug therapy; D012481:Salmonella Infections, Animal / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D005461:Fluorine; D000409:Alanine